Filing Details
- Accession Number:
- 0001209191-19-020568
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-20 16:26:21
- Reporting Period:
- 2019-03-18
- Accepted Time:
- 2019-03-20 16:26:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1515673 | Ultragenyx Pharmaceutical Inc. | RARE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1377202 | Shalini Sharp | C/O Ultragenyx Pharmaceutical Inc. 60 Leveroni Court Novato CA 94949 | Cfo & Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-03-18 | 12,000 | $6.86 | 81,157 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-03-18 | 14,800 | $70.00 | 66,357 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-03-18 | 12,000 | $0.00 | 12,000 | $6.86 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 27,878 | 2023-10-31 | No | 4 | M | Direct |
Footnotes
- Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
- The sales reported on this Form 4 were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- 1/4th of the option vested one year from November 1, 2013 and then 1/48th of the option vested monthly thereafter.
Billionaire Hedge Funds
